By IDSE News Staff
A prophylactic antibody-based immunotherapy protects macaques against severe disease caused by H5N1 avian flu, according to University of Pittsburgh and National Institute of Allergy and Infectious Diseases Vaccine Research Center researchers (Science 2025;387[6733]: 534 doi:10.1126/science.ado6481).
Influenza viruses have a propensity to quickly adapt to new conditions and environments, the researchers noted, which increases the challenge in developing a prophylactic